Recent Updates
Recently added Catalysts
LNTH Negative Sentiment Score: 25/100

LANTHEUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Lantheus Holdings, Inc. on Behalf of Lantheus Stockholders and Encourages Investors to Contact the Firm

Key Takeaway: Bragar Eagel & Squire, P.C. is investigating potential claims against Lantheus Holdings, Inc. on behalf of stockholders due to possible violations of federal securities laws. The firm's investigation comes after Lantheus reported second-quarter results that missed earnings and revenue expectations. Additionally, the company revised its full-year revenue guidance downwards. Following this announcement, Lantheus's stock price experienced a significant drop of 28.58%.

Market Sentiment Analysis

CONCERNS & RISKS

  • Lantheus reported disappointing second quarter results with earnings and revenue missing expectations.
  • The company lowered its full year revenue guidance significantly.
  • The stock price fell by 28.58% following the poor financial results.
  • Pricing pressures in the PSMA PET market have been noted, affecting sales negatively.

Full Press Release Details

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lantheus (LNTH) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Lantheus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH) on behalf of Lantheus stockholders. Our investigation concerns whether Lantheus has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On August 6, 2025, Lantheus announced disappointing second quarter 2025 results, revealing earnings-per-share ("EPS") and revenue figures that missed expectations. In addition, the Company lowered its full year 2025 revenue guidance from $1.550 billion - $1.585 billion to $1.475 billion - $1.51 billion and its full year 2025 adjusted fully diluted EPS guidance from $6.60 - $6.70 per share to $5.50 - $5.70 per share. During an earnings call held that same day, Lantheus's Chief Executive Officer cited intensified pricing pressure in the PSMA PET market and a conscious decision to walk away from volume at certain accounts to protect long-term franchise value. In addition, the Company's Chief Financial Officer stated that "consolidated net revenue for the second quarter was $378 million, a decrease of 4.1%. Radiopharmaceutical oncology currently PYLARIFY contributed $250.6 million of sales, down 8.3%, lower than previously expected."
On this news, Lantheus's stock price fell $20.76 per share, or 28.58%, to close at $51.87 per share on August 6, 2025.
If you purchased or otherwise acquired Lantheus shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.

Tags

Bragar Eagel & Squire

Frequently Asked Questions

How can I contact Bragar Eagel & Squire about Lantheus?

You can reach Brandon Walker or Marion Passmore at (212) 355-4648.

What triggered the investigation into Lantheus?

The investigation follows Lantheus's disappointing second quarter results and earnings miss.

What happened to Lantheus's stock price recently?

Lantheus's stock dropped by 28.58%, closing at $51.87 after the recent announcements.

Is there a cost to contact Bragar Eagel & Squire?

There is no cost or obligation to contact Bragar Eagel & Squire regarding your rights.

What firm is leading the investigation into Lantheus?

Bragar Eagel & Squire, P.C. is the firm conducting the investigation into Lantheus.

Last updated: Sep 11, 2025